Specific immunotherapy. Hypo-sensitisation

被引：0
|
作者：
Merk, H. F. [1 ]
Kapp, A. [2 ]
机构：
[1] Univ Klinikum RWTH Aachen, Klin Dermatol & Allergol, D-52057 Aachen, Germany
[2] Hannover Med Sch, Klin & Poliklin Dermatol & Venerol, D-30449 Hannover, Germany
来源：
HAUTARZT | 2008年 / 59卷 / 07期
关键词：
D O I：
10.1007/s00105-008-1596-x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：536 / 536
页数：1
相关论文
共 50 条
  • [1] Specific immunotherapy.
    Just, J
    Houzel-Charavel, A
    Grimfeld, A
    ARCHIVES DE PEDIATRIE, 1999, 6 : 108S - 113S
  • [2] Allergen-specific immunotherapy. Hyposensitization
    Wedi, B
    Kapp, A
    HAUTARZT, 2004, 55 (04): : 399 - 407
  • [3] Control of autoimmune diseases by epitope specific immunotherapy.
    Billetta, Rosario
    Omori, Mayuko
    Kaspar, Allan
    Ghahromani, Negor
    Brigham, Daniel
    Meschter, Carol
    Lanza, Paolo
    Albani, Salvatore
    CLINICAL IMMUNOLOGY, 2006, 119 : S118 - S118
  • [4] Position paper on the specific allergen immunotherapy. Part 4
    Jutel, Marek
    Cichocka-Jarosz, Ewa
    Kupczyk, Maciej
    ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2019, 6 (01) : 1 - 2
  • [5] Sex-specific genomic determinants of response to immunotherapy.
    Scott, Susan C.
    Shao, Xiaoshan M.
    Niknafs, Noushin
    Balan, Archana
    Lanis, Mara
    White, James
    Forde, Patrick
    Marrone, Kristen
    Lam, Vincent
    Feliciano, Josephine
    Levy, Benjamin
    Brahmer, Julie
    Ettinger, David
    Velculescu, Victor
    Karchin, Rachel
    Hann, Christine
    Naidoo, Jarushka
    Anagnostou, Valsalmo
    CANCER RESEARCH, 2021, 81 (13)
  • [6] Immune responses to antigen-specific cancer immunotherapy.
    Jaeger, E
    Jaeger, D
    Knuth, A
    ANNALS OF ONCOLOGY, 2000, 11 : 41 - 42
  • [7] Allergen immunotherapy.
    Esch R.E.
    Portnoy J.
    Current Allergy and Asthma Reports, 2001, 1 (6) : 491 - 497
  • [8] The future of immunotherapy.
    Bousquet, J
    Demoly, P
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 2000, 40 (07): : 706 - 712
  • [9] Allergen-specific immunotherapy. Present state and directions for the future
    Malling, HJ
    ALLERGY, 1999, 54 : 30 - 33
  • [10] Nme2 as an attractive target for leukemia specific immunotherapy.
    Dietrich, T.
    Jilo, A.
    Cross, M.
    Niederwieser, D.
    Tschiedel, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 308 - 309
12345